The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the .... ever been treated with Trovan, and then only after all other antibiotics failed.
Harriette STEIN, Personal Representative of the Estate of Carl Stein, et al. v. ... The issue before us is whether Pfizer Inc., appellee, may be deemed an ...... Taylor, for use and benefit of Wilson, 222 S.W.2d 820 (Ark.1949); Commn'rs of State ...
Arthur Ray BOWLING, et al., Plaintiffs, v. PFIZER, INC., et al., Defendants. ... James Ralph Adams, Frost & Jacobs 1, Cincinnati, OH, for Pfizer Inc., Shiley Inc.
Sep 22, 2008 ... PFIZER, INC.; PDK Labs, Inc.; Warner Lambert Company, LLC; Johnson ... Rock, AR, on the brief, for appellees, Pfizer, Inc., Warner Lambert and Johnson & Johnson. ... pleadings, we view all the facts pleaded by the Counties, the nonmovants, as true, ..... Wilson, 329 Ark. 143 , 947 S.W.2d 349 , 356 (1997).
Aug 8, 2016 ... Rabi Abdullahi v Pfizer, Inc. Court: United States Court of Appeals for the Second Circuit. Citation: Docket Nos: 05-4863-cv (L), 05-6768-cv ...
Apr 11, 2017 ... THE UNITED STATES OF AMERICA, et al.,. : ex rel. ... Presently before the Court is Defendant Pfizer Inc.'s Second Motion to Dismiss. (ECF. No.
Oct 27, 2015 ... ... TYSSE, LAMPLEY. & LAKIS, LLP, Washington, D.C., for Amicus Equal Employment ... of summary judgment to Pfizer, Incorporated, in an action under ... Stephenson was, by all accounts, an exemplary salesperson. Early in her .... Wilson v. Dollar Gen. Corp., 717 F.3d 337, 342 (4th Cir. 2013). Summary ...
May 11, 2015 ... civil or bankruptcy action, all parties to the action in the district court are considered ..... Wilson v. Dollar General Corp., 717 F.3d 337 (4th Cir. 2013) . .... the Americans with Disabilities Act (ADA), 42 U.S.C. §§ 12101 et seq., as.
All decisions filed in the current term of the Supreme Court of Appeals of West ... 05/22/2018, 17-0432 & 17-0325, L&D Investments, Inc. et al. v. ... 05/18/2018, 17- 0539, Eugene M. Wilson v. ... Pfizer, Inc, Roerig, a Division of Pfizer Inc., et al.